baber/WOPTO huggingface dataset:
Patent CA-2643255-A1 (CA)
Inventor: KOGANOV MICHAEL
IPC: A01N65/00
Filed: 2007-02-21
Abstract: The present invention relates to bioactive ingredients that include isolated bioactive fractions derived from cell juice of fresh biomass of a feverfew (Tanacetum partheniuni) plant. The bioactive fractions are either free of or substantially free of .alpha.-unsaturated .gamma.-lactones (e.g., parthenolide). Further, the bioactive fractions have anti-inflammatory and antioxidant activity. The present invention also relates to a method for isolating a bioactive fraction that is derived from cell juice of fresh biomass of a feverfew (Tanacetum partheniuni) plant and that is at least substantially free of .alpha.-unsaturated .gamma.-lactones (e.g., parthenolide). The present invention also relates to a method for preparing a stabilized cell juice serum fraction and a stabilized concentrated cell juice serum fraction that are free of .alpha.-unsaturated .gamma.-lactones (e.g., parthenolide). The present invention also relates to a bioactive composition that includes a mixture of one or more of the isolated bioactive fractions of the present invention.
Patent CA-2643907-A1 (CA)
Title: Volume measurement using gas laws
Inventor: CARLISLE JEFFREY A
IPC: G06F19/00
Filed: 2007-01-23
Abstract: A system and method for measuring fluid volume and changes in fluid volume over time, using a simple, low cost architecture is described.
Patent CA-2644858-A1 (CA)
Title: A two valves switching modulator for comprehensive two-dimensional gas chromatography
Inventor: WANG FRANK CHENG-YU
IPC: B01D53/02
Filed: 2007-03-13
Abstract: The present invention is an improvement to two-dimensional comprehensive gas chromatography. The improvement is a two-valve switching modulator connecting two different type of separation columns. The advantages of current invention are (1) a simple system can be built by readily available parts; (2) no specific materials required (other than electricity) to operate the system, especially, do not need any type of coolant; (3) can be build on any GC as an externally added on unit; (4) The first and the second dimensional column flow are independently controlled, it is easier to design the experiment; and (5) it is cost effective, the cost of building this system is inexpensive than other type of modulation.
Patent CA-2645303-A1 (CA)
Inventor: KOTANI TAKAYUKI
IPC: A61J1/14
Filed: 2007-03-08
Abstract: An infusion solution bag package that through avoiding of fusion bonding of a sealant layer of exterior bag to an infusion solution bag, realizes easily taking out of the infusion solution bag from the exterior bag. There is provided an infusion solution bag package comprising infusion solution bag (2) having an infusion solution hermetically sealed in a packing bag and exterior bag (3) hermetically enclosing the infusion solution bag (2), wherein the packing bag is made of a polypropylene film, while the exterior bag (3) has its outer layer (4) made of a polyester resin layer and has its sealant layer (7) made of a polypropylene resin layer containing a polypropylene with ultrahigh molecular weight.
Patent CA-2649349-A1 (CA)
Title: Spirocyclic cyclohexane derivatives having an analgesic action
Inventor: SUNDERMANN BERND
IPC: C07D491/10
Filed: 2007-04-25
Abstract: The current invention relates to a spirocyclic cyclohexane derivative of formula (I), a process for its manufacture, medical drugs that contain this bond and the use of spirocyclic cyclohexane derivatives for the manufacture of medical drugspharmaceuticals. The bonds are suited for the treatment of pain.
Patent CA-2649397-A1 (CA)
Title: Aube bi-pale avec lames
Inventor: ROUTIER PASCAL
IPC: F01D9/02
Filed: 2009-01-08
Abstract: L'invention concerne une aube (100) possédant un bord d'attaque (102) et un bord de fuite (103). Cette aube (100) comprend une première pale (10) possédant une face interne (15) et une face externe (14) qui s'étendent entre ledit bord d'attaque (102) et ledit bord de fuite (103), une deuxième pale (20) possédant une face interne (24) et une face externe (25) qui s'étendent entre ledit bord d'attaque (102) et ledit bord de fuite (103), et au moins une lame (30) reliant ladite face interne (15) de la première pale (10) et ladite face interne (24) de la deuxième pale (20), ladite au moins une lame (30) s'étendant jusqu'audit bord de fuite (103), la distance (D) entre la face interne (15) de la première pale et la face interne (24) de la deuxième pale étant de l'ordre de grandeur de l'épaisseur maximale de la première (10) ou deuxième pale (20).
Patent CA-2651239-A1 (CA)
Title: Virus susceptibility by plant nucleosomes
Inventor: HEDEN LARS-OLOF
IPC: A61K36/00
Filed: 2007-05-03
Abstract: ' The present invention relates to the use of a proteinaceous component isolated from plant chromatin, after dissociation of the same, as an antiviral agent. The proteinaceous plant component is produced by means of a method comprising the steps of homogenizing a plant material in order to expose its plant chromatin, dissociating the plant chromatin with a dissociating agent under hydrophobic conditions, and separating the dissociated plant chromatin into individual fractions, one comprising the proteinaceous plant component, by means of a hydrophobic interaction separation procedure. The invention further encompasses a method for treating viral infections in technical as well as pharmaceutical applications.
Patent CA-2651264-A1 (CA)
Title: Paperboard material with expanded polymeric microspheres
Inventor: NYMAN GARY WAYNE
IPC: D21H21/54
Filed: 2007-05-07
Abstract: The present invention is related to a paperboard product having a basis weight in a range of 100 to 350 pounds per 3,000 square feet. The paperboard comprises at least one coated surface suitable for printing. The at least one coated surface comprising cellulosic fibers and from about 0.05 to about 0.5 wt. % dry basis expanded synthetic polymer microspheres based on total weight of the of cellulosic fiber dispersed thereof. The coated surface has a Parker smoothness less than about 2.0 and a Hagerty/Sheffield smoothness not less than about 20 Sheffield units.
Patent CA-2654752-A1 (CA)
Inventor: FISHER LAURA MICOL
IPC: E04B1/346
Filed: 2007-06-18
Abstract: A rotatable building structure (10) contains a vertical central core (14) for supporting suspended floor units (12) surrounding the core. An annular platform (22) extends from the core at corresponding floor units for providing accessibility to and from the central core. The floor units contain a drive mechanism (38, 40, 42) for rotational displacement. The wind load on the exterior side of each floor, and/or horizontal wind turbines that turn around the core but is a separate part of the floor itself, solar panels situated as a roof cover on top of each floor and a wind tool (46) deployable from the floor unit provides alternative wind power assist for rotating the floor units.
Patent CA-2654761-A1 (CA)
Inventor: WALLEY KEITH R
IPC: A61P29/00
Filed: 2007-06-11
Abstract: The invention provides methods, nucleic acids, compositions and kits for predicting a subject's outcome with an inflammatory condition and a subject's response to treatment with activated protein C or protein C like compound to identify subjects having a greater benefit from treatment with activated protein C. The method generally comprises determining a interferon gamma (IFNG) gene polymorphism genotype(s) of a subject for one or more polymorphisms in the IFNG gene or associated sequence, comparing the determined genotype with known genotypes for the polymorphism that correspond with an improved response polymorphism to identify potential subjects having an inflammatory condition who are more likely to benefit from treatment with activated protein C or protein C like compound and subsequent to treatment recover from the inflammatory condition. The invention also provides for methods of treating such subjects with an anti-inflammatory agent or anti-coagulant agent based on the subject's genotype.
Patent CA-2655482-A1 (CA)
Inventor: GIULIANI NICOLA
IPC: B65B35/50
Filed: 2007-06-04
Abstract: There is described a machine for forming groups of ordered products, each group comprising products disposed according to superposed layers (S). The machine comprises a succession of conveyors (5, 9, 11) aligned according to a principal direction (T) of alignment, with a feed conveyor and a delivery conveyor. The feed conveyor (5) receives single layers of products aligned with and spaced from one another; and the conveyors are disposed and controlled so as to distribute layers of products on a predetermined number of levels at different heights, and to unload onto the delivery conveyor a predetermined number of layers, superposed on one another, equal to the predetermined number of said levels at different heights.
Patent CA-2655602-A1 (CA)
Inventor: FONG SCOTT
IPC: E04F21/165
Filed: 2009-02-23
Abstract: A paper beading apparatus, includes a hopper having a body defining a chamber for holding a quantity of joint compound, and having an open upper end, an upper rim, and a lower end; a lid pivotally secured to the body for movement between an open position and a closed position, wherein in the closed position, the lid engages the open upper rim, the lid having a releasably sealable air port; and a base configured for and accommodating the hopper lower end, for receiving joint compound, and for applying the joint compound to a corner paper bead.
Patent CA-2660549-A1 (CA)
Title: Portable board holding apparatus for martial arts
Inventor: WISNIEWSKI TERRY
IPC: A63B69/00
Filed: 2009-04-01
Abstract: A board holding apparatus for martial arts which includes a body having handles, elongate attachment member anchor points and at least one pair of board support mountings. A pair of collapsible board supports are movably secured normal to the body at the board support mountings.
Patent CA-2664284-A1 (CA)
Title: Method and system for offline indexing of content and classifying stored data
Inventor: PRAHLAD ANAND
IPC: G06F17/30
Filed: 2007-10-17
Abstract: A method and system for creating an index of content without interfering with the source of the content includes an offline content indexing system that creates an index of content from an offline copy of data. The system may associate additional properties or tags with data that are not part of traditional indexing of content, such as the time the content was last available or user attributes associated with the content. Users can search the created index to locate content that is no longer available or based on the associate attributes.
Patent CA-2666587-A1 (CA)
Inventor: MOESCHWITZER JAN P
IPC: A61K9/20
Filed: 2007-10-19
Abstract: The present invention relates to a thermostable solid composition containing nanosized micelles, the micelles containing a poorly soluble chemical substance, such as a biologically active substance, dissolved in an auxiliary material, and the micelles being embedded in a water soluble carrier. The invention further relates to a process for preparing a thermostable solid composition and to a process for preparing pharmaceutical dosage forms comprising the same.
Patent CA-2668080-A1 (CA)
Inventor: MOHAT NICHOLAS C
IPC: B64C1/14
Filed: 2009-06-02
Abstract: A modular window for use in a vehicle, such as an airborne vehicle, is provided.  The modular window includes a suspended particle device ("SPD") film, the SPD  film making up one of the lenses of the modular The window typically includes an opaque shade movable between an opened and closed position, in spaced apart relation to the reveal mounted SPD lens. The opaque shade can move between an open and closed position with the opaque shade. In an open position, the light passing through the modular window unit is controlled by controlling the opacity of the SPD lens.  When the opaque shade is in a closed position, the opaque shade substantially prevents any light from passing through the modular window unit regardless of the opacity of the SPD lens.
Patent CA-2668722-A1 (CA)
Inventor: KORNMAN KENNETH S
IPC: C12Q1/68
Filed: 2007-11-15
Abstract: The invention provides methods and compositions relating to identification and use of genetic information from the IL-I gene cluster - including the structure and organization of novel IL-1-like genes found within the IL-I locus as well as polymorphisms and associated haplotypes within these genes. The invention thereby expands the repertoire of useful genetic information available from the IL-I locus - which contains the previously-identified IL-l.alpha., IL-l.beta. and EL- IRN genes, for predicting IL-I associated phenotypes (e.g. increased or decreased risks of insulin resistance associated pathologies) and for treating EL-I haplotype associated insulin resistance associated pathologies.
Patent CA-2668973-A1 (CA)
Title: Chip module for an rfid system
Inventor: SCHAFFRATH KAI
IPC: G06K19/077
Filed: 2007-10-16
Abstract: The invention relates to a chip module for an RFID system, in particular for an RFID-label, a coupling label for use in an RFID-label, an RFID-Inlay for an RFID-label, and an RFID label produced using an RFID inlay on a strip-shaped backing material (5, 8), in particular a backing film; an RFID chip (3) and a coupling antenna (4) that is electrically, in particular galvanically, connected to the RFID-chip (3), are arranged on the strip-shaped backing material.
Patent CA-2669475-A1 (CA)
Title: Tissue carbohydrate compositions and analysis thereof
Inventor: SATOMAA TERO
IPC: G01N33/50
Filed: 2006-11-08
Abstract: The present invention reveals novel methods for producing novel carbohydrate compositions, glycomes, from animal tissues. The tissue substrate materials can be total tissue samples and fractionated tissue parts, or artificial models of tissues such as cultivated cell lines. The invent ion is further directed to the compositions and compositions produced by the methods according to the invention. The invention further represent methods for analysis of the glycomes, especially mass spectrometric methods.
Patent CA-2670080-A1 (CA)
Inventor: DYSON MAJA
IPC: C09D7/48
Filed: 2007-11-20
Abstract: An oxygen sensitive ink or coating with enhanced photostability, comprising an oxygen sensitive indicator, a photostabilizer, an oxygen permeable binder and a solvent mixture is provided. The oxygen sensitive indicator is selected from, but not limited to [Ru(L 1)(L2)(L3)]2+, wherein Ru represents the central ruthenium ion, Ll, L2 and L3 represent the bidentate ligands diphenylphenanthroline, phenanthroline or bipyridine ligands or optionally substituted variations of same with representative counter ions selected from (PF6)-, Cl-, BF4-, Br- and (C104)-, platinum or palladium based metallo- porphyrin. The photostabilizer is selected from, but not limited to CIBA TINUVIN 5236, TINUVIN 292, TINUVIN 123 and TINUVIN 272, TINUVIN 477W, DABCO and ascorbic acid. Oxygen sensitive elements incorporating the oxygen sensitive ink or coating are manufactured by printing on a continuous flexible or rigid substrate using printing method including ink-jet, gravure, flexographic, pad printing or pin printing.
Patent CA-2670165-A1 (CA)
Title: 2-[(2-substituted)-ind0lizin-3-yl]-2-oxo-acetamide derivatives as antifungal agents
Inventor: DAVIES GARETH MORSE
IPC: A01N43/90
Filed: 2007-11-21
Abstract: The invention provides compounds of formula (I), and pharmaceutically acceptable salts thereof wherein: Rl, R2, R3, R4, R5, R6, R7, X and X1 are as defined herein. These compounds are useful in the manufacture of medicaments for use in the prevention or treatment of a fungal disease. Compounds of formula (I), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.
Patent CA-2671565-A1 (CA)
Inventor: PACE WILLIAM
IPC: G06F19/00
Filed: 2007-12-03
Abstract: The present disclosure provides methods and apparatuses for generating toxicology reports. Using the methods and apparatus disclosed herein, physicians can more easily understand toxicological lab test results. Physicians receive a toxicology report that explains, in plain language, the toxicological lab test results. A rules engine provides rules for interpreting the toxicological lab test results. Detailed explanations are associated with the rules, and the explanations appear on the toxicology report. The toxicology report greatly reduces the need for the physician to call the toxicology scientist.
Patent CA-2673246-A1 (CA)
Title: A method and arrangements for an event triggered drx cycle adjustment
Inventor: KAZMI MUHAMMAD
IPC: H04W76/04
Filed: 2007-12-10
Abstract: The invention relates to methods and arrangements for an event triggered DRX cycle adjustment. A user equipment located in a serving cell of a mobile communications network monitors downlink communication at predetermined time intervals when operating in discontinuous reception mode. The user equipment also performs communication parameter measurements regarding at least one of the serving cell and one or more neighbour cells. After the occurrence of a first event, the user equipment sends at least one of measurement data and a first event report to the network. The sending is triggered by the occurrence of the first event. The monitoring is caused to be performed at shortened time intervals after the occurrence of a second event, wherein the second event is defined to indicate a higher probability of receiving a handover command than the first event.
Patent CA-2673545-A1 (CA)
Inventor: LEONARDI AMEDEO
IPC: A61P13/10
Filed: 2007-12-21
Abstract: The administration to a mammal of a combination of compounds, at least one of which is an .alpha.2.delta. calcium channel subunit (A2d) ligand and at least one of which is a non-steroidal anti-inflammatory drug (NSAID), provides a surprising and potent inhibition of the micturition reflex, superior to that obtained by treatment with an A2d ligand or NSAID alone. Combinations of A2d ligand and NSAIDs are thus useful for treatment of lower urinary tract disorders and symptoms thereof. Preferred A2d ligands are gabapentin and pregabalin. Preferred NSAIDs are celecoxib, diclofenac, diflunisal, flurbiprofen, naproxen, nimesulide or sulindac.
Patent CA-2675629-A1 (CA)
Title: New salt
Inventor: AVITABILE BARBARA GIUSEPPINA
IPC: C07D263/12
Filed: 2008-02-06
Abstract: The invention provides [2-(4-chloro-benzyloxy)-ethyl]-[2-((R)-cyclohexyl-hydroxy- phenyl-methyl)-oxazol-5-ylmethyl]-dimethyl-ammonium napadisylate, pharmaceutical compositions containing it, and its use in therapy.
Patent CA-2676336-A1 (CA)
Inventor: TEPLITSKY ALEXANDER ARKADIEVICH
IPC: F23G5/027
Filed: 2007-12-11
Abstract: The inventive method for recovery of tires, mainly waste tires, consists in supplying waste tires to a pyrolysis column, in exposing the tires to the action of variable magnetic field in such a way that they are heated to a temperature of rubber thermal decomposition, in removing volatile products which are formed during the rubber thermal decomposition process, in cooling solid residues of the thermal decomposition products and in removing them from the pyrolysis column, wherein the tires are previously divided into parts which are supplied to the pyrolysis column through a feed port and the tires are inductively heated by means of a magnetic field, the frequency of which ranges from 1 to 1000 kHz. A device for carrying out said method is also disclosed.
Patent CA-2676635-A1 (CA)
Title: Fuel cell stack clamping structure and solid oxide fuel cell stack
Inventor: ERIKSTRUP NIELS
IPC: H01M8/24
Filed: 2008-01-24
Abstract: Clamping structure for a planar solid oxide fuel cell stack comprising a flexible sheet and a rigid, thermally insulating end block, the flexible sheet being capable of bending into a primarily convex shape, the rigid, thermally insulating end block shaped as a rectangular base with a planar surface and an opposing surface that is primarily convex in shape, the flexible sheet being placed adjacent to the opposing surface of the rigid, thermally insulating end block, the flexible sheet thereby bending to obtain a shape that is primarily convex. The invention also relates to a solid oxide fuel cell stack and a process for the compression of the stack.
Patent CA-2677631-A1 (CA)
Inventor: SINGH ONKAR N
IPC: A61K9/00
Filed: 2007-02-07
Abstract: Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6 % (w/v) of olopatadine.
Patent CA-2677837-A1 (CA)
Inventor: KELLER VIVIEN
IPC: H01M4/88
Filed: 2008-02-15
Abstract: The present invention describes a method and an apparatus for the electrochemical deposition of fine catalyst particles onto carbon fibre-containing substrates which have a compensating layer ("microlayer"). The method comprises the preparation of a precursor suspension containing ionomer, carbon black and metal ions. This suspension is applied to the substrate and then dried. The deposition of the catalyst particles onto the carbon fibre-containing substrate is effected by a pulsed electrochemical method in an aqueous electrolyte. The noble metal-containing catalyst particles produced by the method have particle sizes in the nanometer range. The catalyst-coated substrates are used for the production of electrodes, gas diffusion electrodes and membrane electrode units for electrochemical devices, such as fuel cells (membrane fuel cells, PEMFC, DMFC, etc.), electrolysers or electrochemical sensors.
Patent CA-2678947-A1 (CA)
Inventor: LIU QINGXIA
IPC: C04B11/00
Filed: 2008-03-18
Abstract: A process for making calcined gypsum in slurry or powder form. The process includes adding at least two types of crystal modifiers to the slurry. The first crystal modifier is to control crystal morphology of the calcined gypsum (such as succinic and/or malic acid). The second crystal modifier is to prevent or retard setting to control set time (such as tetrasodium pyrophosphate (TSPP)) to form a water stable product. An accelerator is typically added at the site of use for specific applications such as setting type joint compound, media casting, exterior/interior coating, and sprayable fireproofing. A composition made by the process and a kit for using the composition are also disclosed.
Patent CA-2680535-A1 (CA)
Title: Binding ligand linked drug delivery conjugates of tubulysins
Inventor: LEAMON CHRISTOPHER PAUL
IPC: A61K47/48
Filed: 2008-03-13
Abstract: Described herein are compounds, pharmaceutical compositions and methods for treating pathogenic cell populations. The compounds described herein include conjugates of tubulysins and vitamin receptor binding ligands. The conjugates also include a releasable bivalent linker.
Patent CA-2680814-A1 (CA)
Inventor: SHOHAT SHAUL
IPC: A61B17/04
Filed: 2008-03-13
Abstract: Remodeling of body tissue using a bioabsorbable implant that maintains or otherwise mechanically assists a more permanent implant or other treatment take, for example, by the treatment causing fibrosis. For example, the apparatus and methods can be used for hernia, organ prolapse and cosmetic purposes, such as breast and face lifts.
Patent CA-2682036-A1 (CA)
Title: Usership-based distribution
Inventor: XU XIN
IPC: G06Q10/08
Filed: 2009-10-15
Abstract: A method of distribution comprises providing a distributorship data storage for storing a plurality of user distributorship records and providing a usership-based order processing unit for processing each usership acquiring order involving a distributing member, a distributee and a distributed product or service entity, wherein said order is processed by said order processing unit by affirming said distributee's user distributorship of said distributed entity and making a commission payment to said distributing member if said distributing member is a distributor of said distributed entity.